Feedback / Questions
FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus Biosci, Teva
https://www.globenewswire.com/news-release/2021/10/04/2307860/33333/en/Positive-Results-of-Clinical-Trial-Comparing-Coherus-Ranibizumab-Biosimilar-Candidate-CHS-201-to-Reference-Product-Lucentis-Ranibizumab-in-the-Treatment-of-Neovascular-Wet-Age-Rela.html
Oct 4, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next